G Medical Innovations announces receipt of patent from USPTO for vital signs sensors
February 13, 2023 09:00 ET
|
G Medical Innovations Holdings Ltd.
Rehovot, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that the patent US 11,571,167 “Method...
G Medical Innovations announces receiving notice of patent issuance from the USPTO for vital signs sensors
January 30, 2023 06:15 ET
|
G Medical Innovations Holdings Ltd.
Rehovot, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today announced that it has received a patent issue...
G Medical Innovations to announce receiving of 2 (two) granted patents from the USPTO for its Prizma care and other physiological sensors developed by the company.
December 05, 2022 09:27 ET
|
G Medical Innovations Holdings Ltd.
Irvine, California, Dec. 05, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that it received 2 (Two) granted...
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Notice of Deficiency with Nasdaq Continued Listing Requirements
November 22, 2022 12:27 ET
|
G Medical Innovations Holdings Ltd.
Irvine, California, Nov. 22, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company...
G Medical Innovations Announces First Half 2022 Financial Results and Provides Business Update
November 18, 2022 17:15 ET
|
G Medical Innovations Holdings Ltd.
Irvine, CA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (“G Medical” or the “Company”), an early commercial stage healthcare company engaged in the...
G Medical Innovations is introducing a Monkeypox consumer home health test kit, along with 30 new direct to consumer home health testing kits with 24 to 48 hours results
October 06, 2022 09:27 ET
|
G Medical Innovations Holdings Ltd.
October 6, 2022 IRVINE, California, Oct. 06, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company” or “G Medical Innovations”) today announced that its...
G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results
July 13, 2022 06:15 ET
|
G Medical Innovations Holdings Ltd.
The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for...
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price Notification
June 17, 2022 16:25 ET
|
G Medical Innovations Holdings Ltd.
Irvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company...
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase Program
May 20, 2022 09:00 ET
|
G Medical Innovations Holdings Ltd.
Irvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase...
(Correction) G Medical Innovations Holdings Ltd Announces $7.5 Million Private Placement
April 18, 2022 09:11 ET
|
G Medical Innovations Holdings Ltd.
TEL AVIV and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ:GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company...